ICON
-
ICON, Empire Genomics enters into partnership
ICON and Empire Genomics will partner to develop a service portfolio tailored to the development of personalised medicines. The partnership combines Empire Genomics’ expertise in pharmacogenomics, computational modeling of disease state, drug disposition and drug targets with ICON’s expertise in translational medicine, clinical trial design and biomarkers.
ICON | 15 February 2012
-
DOCS continues expansion with four new offices in Europe
ICON announced that its resourcing division, DOCS, has expanded in Europe by opening four new offices: in Milan, Italy; Budapest, Hungary; Brussels, Belgium and Berlin, Germany. This latest expansion brings the total number of DOCS offices in Europe to 22.
ICON | 03 February 2012
-
ICON wins award at the Annual Scrip Awards
ICON has won the Clinical Research Team of the Year award at the annual 2011 Scrip Awards.
ICON | 18 January 2012
-
ICON Acquires BeijingWits Medical Consulting
ICON has agreed, subject to closing conditions, to acquire BeijingWits Medical Consulting, a leading CRO in China. The transaction is expected to close in the first quarter of 2012.
ICON | 11 January 2012
-
ICON Medical Imaging is rated as top provider in imaging industry survey
ICON announced that its medical imaging division was rated as the top provider of imaging services according to an industry survey conducted by Blue Pyramid Consulting, an affiliate of the Avoca Group.
ICON | 05 January 2012
-
ICON Development Solutions appoints general manager of Asia Pacific
ICON announced that its development solutions division has appointed Dr Daniel Tang as general manager, Asia Pacific. Dr Tang will lead the development of ICON’s early phase activities across the region, including bioanalytical laboratory services, and the development of strong links with key opinion leaders for early phase clinical testing.
ICON | 12 December 2011
-
ICON names global head of clinical research services
ICON announced that Dr Steve Cutler will join the company as group president, clinical research services. Dr Cutler has over 23 years’ experience within the pharmaceutical and CRO industry and joins ICON from Kendle where he held the position of chief executive officer, having previously served as Kendle’s chief operating officer.
ICON | 29 November 2011
-
Biomarkers Consortium of the FNIH selects ICON to support study evaluating variability in insulin secretory parameters
ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced it has received a contract award from the Foundation for the National Institutes of Health (FNIH) to provide clinical support for the Biomarkers Consortium study entitled Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects.
ICON | 31 October 2011
-
ICON to support study evaluating variability in insulin secretory parameters
Selected by Biomarkers Consortium of the FNIH.
ICON | 21 October 2011
-
ICON appoints Colin Stanley President of DOCS
Succeeds Bill Taaffe as President following his retirement earlier this year.
ICON | 17 October 2011
